Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.17541 | 48 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.12768 | 48 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.12644 | 48 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.05642 | 47 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.06394 | 47 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.20412 | 47 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.25182 | 49 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.10951 | 47 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.09452 | 47 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.12015 | 48 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.12096 | 48 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.05772 | 47 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.12676 | 47 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.12638 | 48 |